Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 1,568 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Regimen Clear all

Conditions: Diabetes Mellitus Type 2
Interventions: Lixisenatide (AVE0010), Placebo, Pen auto-injector, Pioglitazone, Metformin; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 85
States / cities: Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 72 more

Conditions: Smoking, Smoking Cessation
Interventions: Tobacco Treatment; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 706 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: MBL949, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: Miami, Florida • Morehead City, North Carolina • Knoxville, Tennessee + 1 more

Conditions: COVID-19, Pneumonia
Interventions: Heparin; Drug
Lead sponsor: University of Manitoba; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 13
States / cities: Atlanta, Georgia • Chicago, Illinois • Jefferson, Louisiana + 10 more

Conditions: HIV
Interventions: PRO 140; Biological
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Phildadelphia, Pennsylvania

Conditions: Acute Lymphoblastic Leukemia
Interventions: Gross Motor Function, Knee extension strength, Hand grip strength, Flexibility, Ankle range of motion, Aerobic capacity, Body composition and vital signs; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 5 Years to 10 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 4
States / cities: Portland, Oregon • Philadelphia, Pennsylvania • Memphis, Tennessee + 1 more

Conditions: PTSD, Alcohol Abuse, Alcoholism
Interventions: Topiramate, Placebo administration; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pregnancy Related, Pre-Eclampsia
Interventions: Modified natural cycle, Programmed cycle; Procedure
Lead sponsor: JHSPH Center for Clinical Trials; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 788 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 15
States / cities: San Francisco, California • Sunnyvale, California • Orange, Connecticut + 12 more

Conditions: Alcohol Withdrawal, Alcohol Withdrawal Delirium
Interventions: Phenobarbital, Lorazepam; Drug
Lead sponsor: OSF Healthcare System; Other
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Knee Osteoarthritis, Pain, Postoperative
Interventions: Multimodal analgesia including pregabalin, Multimodal analgesia not including pregabalin; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Great Neck, New York

Conditions: Rib Fractures, Rib Trauma, Rib Fracture Multiple, Pain, Acute
Interventions: lidocaine, ketamine intravenous infusion, paravertebral block with ropivicaine; Combination Product · Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Malaria, Malaria,Falciparum
Interventions: PfSPZ Vaccine, PfSPZ Challenge (7G8), Normal Saline; Biological · Other
Lead sponsor: Sanaria Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Human Immunodeficiency Virus
Interventions: 3-drug anti-HIV therapy, Raltegravir; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetes Mellitus, Type 1
Interventions: Parent mentors; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 10 Years to 15 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Ulcerative Colitis
Interventions: Ozanimod, Placebo; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 73 Years
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 10
States / cities: Anaheim, California • La Jolla, California • Oceanside, California + 7 more

Conditions: Athletic Performance, Recovery, Sleep
Interventions: Magnesium glycinate, Magnesium L-threonate, Placebo; Dietary Supplement · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 35 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Elective Cesarean Section, Pain Management
Interventions: 50 mcg Duramorph+ EXPAREL + multi-modal pain regimen, 150 mcg Duramorph + multi-modal pain regimen, Exparel TAP + multi-modal pain regimen; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 18
States / cities: Stanford, California • Gainesville, Florida • Jacksonville, Florida + 13 more

Conditions: Overactive Bladder
Interventions: Fesoterodine, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 963 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 112
States / cities: Mobile, Alabama • Goodyear, Arizona • Litchfield Park, Arizona + 99 more

Conditions: Early Stage Breast Cancer (Stage 0-III)
Interventions: Exercise Regimen; Other
Lead sponsor: Nevada Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Radiation Dermatitis
Interventions: Chlorhexidine gluconate solution, Mupirocin Ointment; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Snakebites, Envenoming, Envenoming, Snake, Envenomation, Snake
Interventions: Varespladib Methyl, Placebo, Standard of care (SOC); Drug
Lead sponsor: Ophirex, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Tucson, Arizona • Loma Linda, California • Jacksonville, Florida + 5 more

Conditions: Growth Hormone Deficiency
Interventions: NuSpin, Somatropin; Device · Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 2 Years to 14 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 14
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Sacramento, California + 11 more

Conditions: Healthy
Interventions: Dimethyl Fumarate (BG00012), Aspirin, BG00012 matching placebo, ASA matching placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease
Interventions: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen; Biological
Lead sponsor: Mercy Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)

PRO 140 for Human Immunodeficiency Virus

Aerobic and Strengthening Exercise for Acute Leukemia

Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

Influence of Patient Sex on Pain Control and Multimodal Analgesia in Total Knee Arthroplasty

PVB vs Ketamine/Lidocaine in Rib Fracture Patients

A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI

Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1

Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

UCLA Magnesium Formulation Athlete Study

Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section

A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory

Bacterial Decolonization to Prevent Radiation Dermatitis

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite

A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device

Alternate Dosing Regimens of BG00012 in Healthy Volunteers

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis